Caprico Biotechnologies CD79a APC-Cyanine7 catalog number: 115194，CD79 consist of two proteins, namely CD79a and CD79b. CD79a recognizes the Ig-alpha protein, and CD79b recognizes the Ig-beta protein of the B-cell antigen component of the B-lymphocyte antigen receptor.
Caprico Biotechnologies CD79a PE catalog number: 115124，CD79 consist of two proteins, namely CD79a and CD79b. CD79a recognizes the Ig-alpha protein, and CD79b recognizes the Ig-beta protein of the B-cell antigen component of the B-lymphocyte antigen receptor.
Caprico Biotechnologies CD79a PE-Cyanine5 catalog number: 115174，CD79 consist of two proteins, namely CD79a and CD79b.
Caprico Biotechnologies CD79a PE-Cyanine7 catalog number: 115184，CD79 consist of two proteins, namely CD79a and CD79b.
Caprico Biotechnologies CD79a PerCP-Cyanine5.5 catalog number: 115164，CD79 consist of two proteins, namely CD79a and CD79b.
Caprico Biotechnologies CD79a Unconjugated catalog number: 115101，CD79 consist of two proteins, namely CD79a and CD79b. CD79a recognizes the Ig-alpha protein, and CD79b recognizes the Ig-beta protein of the B-cell antigen component of the B-lymphocyte antigen receptor.
Vactosertib (CAS No.: 1352608-82-2), is a potent, orally active and ATP-competitive activin receptor-like kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM.. >99% Purity. Synonyms: EW-7197, TEW-7197, EW7197, TEW7197, ALK5 inhibitor, ATP-competitive activin receptor-like kinase...
Nazartinib (EGF-816) (CAS No.: 1508250-71-2), a covalent mutant-selective EGFR inhibitor, with Ki and Kinact of 31 nM and 0.222 min-1 on EGFR(L858R/790M) mutant, respectively. >98% Purity. Synonyms: EGF-816, EGF816, EGFR inhibitor, epidermal growth factor receptor inhibitor For...
JNJ-4796 (CAS No.: 2241664-16-2), an oral active fusion inhibitor of influenza virus, neutralizing influenza A group 1 viruses by inhibiting hemagglutinin (HA)-mediated fusion. >98% Purity. Synonyms: JNJ4796, fusion inhibitor, influenza virus inhibitor For Research Use Only.
DEL-22379 (CAS No.: 181223-80-3), a potent and selective ERK Dimerization inhibitor. DEL-22379 inhibits ERK Dimerization without affecting ERK phosphorylation, forestalls tumorigenesis driven by RAS-ERK pathway oncogenes. Nearly 50% of human malignancies exhibit unregulated RAS-ERK...
